RUBY - Rubius Therapeutics Inc
Previous close
0.057
0 0%
Share volume: 755,858
Last Updated: Fri 29 Dec 2023 06:00:00 AM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.06
0.00
0.00%
Summary score
6%
Profitability
0%
Dept financing
7%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.95%
Return on assets
-9.8%
Return on sales
0%
Return on invested capital
-120.06%
Total debt ratio
22.66%
Debt ratio change over timeo
-1.3%
Current Ratio
14.76%
Quick Ratio
0%
Cash Position Ratio
8.92%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.64%
Return on assets
-11.92%
Return on sales
0%
Return on invested capital
-61.92%
Total debt ratio
33.07%
Debt ratio change over timeo
-1.49%
Current Ratio
8.96%
Quick Ratio
0%
Cash Position Ratio
3.93%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.42%
Return on assets
-10.94%
Return on sales
0%
Return on invested capital
-53%
Total debt ratio
40.34%
Debt ratio change over time
-1.62%
Current Ratio
8.44%
Quick Ratio
0%
Cash Position Ratio
4.46%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.8%
Return on assets
-88.26%
Return on sales
0%
Return on invested capital
-12.41%
Total debt ratio
-130.12%
Debt ratio change over time
-1.3%
Current Ratio
-15.83%
Quick Ratio
0%
Cash Position Ratio
-8.8%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RUBY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.95% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.8% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -120.06% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 22.66% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.3% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 8.96% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.93% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 33% | 33% |
| Short-term ratios | RUBY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.64% | -25.62% | 17.94% | 7.14% |
| Return on assets | -11.92% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -61.92% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 33.07% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.49% | -23.44% | 9.66% | 0.6% |
| Dept financing | 8% | 25% | 45% | 8% |
| Current Ratio | 8.96% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.93% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 32% | 25% | 44% |